In a cross-sectional study presented at ASE 2025, two-dimensional speckle tracking echocardiography identified diastolic abnormalities missed by traditional imaging in over 60% of patients with type 2 diabetes.
In a cross-sectional study presented at ASE 2025, two-dimensional speckle tracking echocardiography identified diastolic abnormalities missed by traditional imaging in over 60% of patients with type 2 diabetes.
As ASE marks its 50th anniversary in Nashville, the meeting will showcase the latest echocardiography research, updated guidelines, the Kalmanson Lecture, and discussions on workforce challenges.